Please assess the completion status of the following clinical trial:

Trial Title: Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
INCLUSION CRITERIA:~* Patients must meet the Budapest CRPS criteria, including two or more symptom categories and three or more sign categories (as previously documented by a pain management physician or neurologist, or as observed on initial neurologic examination by the study investigator)~* Patients must have trialed at least three of the following therapies without relief judged adequate by the patient:~* Anti-depressants~* Anti-seizure medication~* Muscle relaxants~* Nerve blocks (somatic or sympathetic)~* Non-opioid analgesics~* Non-steroidal anti-inflammatory drugs~* Opioid analgesics~* Physical therapy~* Spinal cord stimulator trial~* Patients of either gender between the ages of 18 and 65 inclusive~* Patient report of a NRS pain score of at least 5 in at least two out-patient pain management physician clinic visits~EXCLUSION CRITERIA:~* Patients younger than 18 or older than 65~* Patients who:~* Are pregnant~* Are affected with glaucoma~* Are affected with thyrotoxicosis~* Are lactating~* Are on chronic anticoagulation therapy~* Have autonomic dysfunction with hemodynamic instability~* Have cardiac rhythm disturbance~* Have cerebrovascular disease~* Have conditions that would preclude central line placement~* Have conditions that would preclude epidural catheter placement~* Have congestive heart failure~* Have coronary artery disease~* Have creatinine level above 1.5~* Have electrolyte disturbance~* Have had previous reaction to IV contrast dye~* Have history of deep vein thrombosis~* Have history of systemic administration of ketamine for the treatment of pain~* Have liver disease~* Have known history of psychosis, significant thought disorder, or untreated (bipolar disorder depression or anxiety disorder ok)~* Have uncontrolled hypertension~* Any patient who is unable to provide consent due to cognitive difficulties~* Non-English speakers, as some of the instruments are only validated in English~* Patients with active litigation or workers compensation related to CRPS~* Patients with an intolerance or allergy to any medication planned as a component of the study~* Patients with known history of illegal drug use or alcohol dependence

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Ketamine Infusion + Epidural Infusion + Booster Infusion (Type: EXPERIMENTAL): Inpatient: Patients will receive a subanesthetic continuous intravenous infusion of KETAMINE 500mg/500ml in 0.9% Sodium Chloride with an epidural infusion.~Outpatient: Patients will receive three ketamine booster infusions over the course of three months.
- Control Group + Epidural Infusion + Booster Infusion (Type: PLACEBO_COMPARATOR): Inpatient: Patients will receive a subanesthetic continuous intravenous infusion of SALINE 500mg/500ml in 0.9% Sodium Chloride with an epidural infusion.~Outpatient: Patients will receive three saline booster infusions over the course of three months.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues